KW-8232 is an orally bioavailable small molecule developed for osteoporosis research. It functions by inhibiting the biosynthesis of prostaglandin E2 (PGE2). This mechanism has been investigated in both in vitro assays and in vivo animal models for bone metabolism studies.
Molekulargewicht:
705.27
CAS Nummer:
[217813-15-5]
Formel:
C37H41ClN4O6S
Target-Kategorie:
Others,Prostaglandin Receptor,SARS-CoV
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten